Brief: Tenax Therapeutics Announces New US Patent Covering Use Of Levosimendan In Pulmonary Hypertension
30/04/2024 12:39
April 30 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS ANNOUNCES NEW U.S. PATENT COVERING THE
USE OF
LEVOSIMENDAN IN PULMONARY HYPERTENSION WITH HEART FAILURE WITH
PRESERVED EJECTION FRACTION (PH-HFPEF)
Source text for Eikon: ID:nGNX4WWmBs
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))